SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-22-002233
Filing Date
2022-03-21
Accepted
2022-03-21 11:10:39
Documents
1
Group Members
PATRICK G. G. DEARREADE E. GRIFFITHTETRAGON FINANCIAL GROUP LTDTETRAGON FINANCIAL MANAGEMENT L.P.

Document Format Files

Seq Description Document Type Size
1 FREELINE THERAPEUTICS HOLDINGS PLC p22-1104sc13g.htm SC 13G 95890
  Complete submission text file 0000902664-22-002233.txt   97766
Mailing Address 399 PARK AVENUE, 22ND FLOOR NEW YORK NY 10022
Business Address 399 PARK AVENUE, 22ND FLOOR NEW YORK NY 10022 (212) 359-7300
Tetragon Financial Management LP (Filed by) CIK: 0001758892 (see all company filings)

IRS No.: 203311552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Subject) CIK: 0001810031 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91620 | Film No.: 22754615
SIC: 2836 Biological Products, (No Diagnostic Substances)